Want to see HK:1827 full AI Analyst Report?
Top Page
Miricor Enterprises Holdings Ltd
(1827)
Select Model
Select Model
Rating:67Neutral
Price Target:
HK$1.00
▲(5.26% Upside)
Action:Reiterated
Date:09/16/26
The score is primarily supported by improving financial stability (deleveraging) and strong recent cash generation, partially offset by a sharp FY2026 revenue contraction and thin operating margins. Technicals add support with the price above major moving averages and a positive MACD, while valuation remains moderate with a P/E around 12.6 and no dividend yield provided.
Positive Factors
Deleveraging
Meaningful debt reduction and a stronger equity base improve financial resilience and reduce the burden of servicing borrowings. This gives the company greater flexibility to withstand operating volatility, fund ongoing needs, and allocate cash without relying as heavily on leverage.
Negative Factors
Revenue Contraction
A sharp revenue decline weakens the foundation for sustainable earnings and can reduce operating leverage across the business. The consecutive recent declines make growth less dependable over the next several quarters and increase the importance of stabilizing demand before profits can compound.
Read all positive and negative factors
Positive Factors
Negative Factors
Deleveraging
Meaningful debt reduction and a stronger equity base improve financial resilience and reduce the burden of servicing borrowings. This gives the company greater flexibility to withstand operating volatility, fund ongoing needs, and allocate cash without relying as heavily on leverage.
Read all positive factors
Miricor Enterprises Holdings Ltd (1827) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$320.00M
Dividend Yield12.5%
Average Volume (3M)25.50K
Price to Earnings (P/E)18.8
Beta (1Y)-0.16
Revenue Growth-10.11%
EPS Growth6.04%
CountryHK
Employees235
SectorConsumer Cyclical
Sector Strength84
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.04
Shares Outstanding400,000,000
10 Day Avg. Volume27,000
30 Day Avg. Volume25,500
Financial Highlights & Ratios
PEG Ratio5.54
Price to Book (P/B)2.38
Price to Sales (P/S)1.04
P/FCF Ratio5.52
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Miricor Enterprises Holdings Ltd Business Overview & Revenue Model
Company Description
Miricor Enterprises Holdings Limited, an investment holding company, provides non-surgical medical aesthetic, wellness beauty services, and skincare products in Hong Kong and Mainland China. It offers non-surgical medical aesthetic services, inclu...
Miricor Enterprises Holdings Ltd Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
71
Positive
Cash Flow
77
Positive
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 362.39M | 403.15M | 494.26M | 463.12M | 363.92M |
| Gross Profit | 155.25M | 211.13M | 225.37M | 233.49M | 194.32M |
| EBITDA | 84.55M | 106.36M | 86.62M | 70.34M | 94.02M |
| Net Income | 11.23M | 10.59M | -12.62M | -20.50M | 25.38M |
Balance Sheet | |||||
| Total Assets | 423.67M | 471.28M | 479.44M | 516.81M | 476.81M |
| Cash, Cash Equivalents and Short-Term Investments | 258.15M | 192.17M | 182.43M | 116.91M | 65.68M |
| Total Debt | 50.73M | 88.76M | 99.75M | 130.28M | 127.58M |
| Total Liabilities | 265.40M | 323.72M | 342.68M | 366.10M | 305.54M |
| Stockholders Equity | 158.27M | 147.56M | 136.76M | 150.71M | 171.27M |
Cash Flow | |||||
| Free Cash Flow | 68.14M | 112.07M | 58.24M | 72.67M | -67.61M |
| Operating Cash Flow | 74.45M | 114.02M | 84.45M | 99.45M | 44.03M |
| Investing Cash Flow | 32.42M | -30.95M | -59.00M | -37.84M | -97.51M |
| Financing Cash Flow | -45.18M | -50.03M | -55.59M | -21.92M | -28.73M |
Miricor Enterprises Holdings Ltd Technical Analysis
Positive
0.95
Price Trends
0.76
Positive
0.75
Positive
0.76
Positive
Market Momentum
0.01
Positive
48.23
Neutral
14.68
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1827, the sentiment is Positive. The current price of 0.95 is above the 20-day moving average (MA) of 0.82, above the 50-day MA of 0.76, and above the 200-day MA of 0.76, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 48.23 is Neutral, neither overbought nor oversold. The STOCH value of 14.68 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1827.
Miricor Enterprises Holdings Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$1.51B | 8.57 | 43.78% | 11.92% | -14.68% | -13.60% | |
67 Neutral | HK$320.00M | 18.78 | 7.35% | 12.50% | -10.11% | 6.04% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | HK$1.59B | 43.50 | 6.47% | ― | 2.78% | -41.23% | |
56 Neutral | HK$6.03B | 14.09 | 6.50% | 20.98% | ― | ― | |
52 Neutral | HK$284.00M | -28.17 | -77.06% | 3.14% | -38.43% | -394.12% | |
50 Neutral | HK$73.26M | -40.50 | -0.93% | 6.43% | -2.31% | 66.07% |
* Consumer Cyclical Sector Average
HK:1827
Miricor Enterprises Holdings Ltd
0.80
-0.03
-3.38%
HK:1448
Fu Shou Yuan International Group
2.64
-0.06
-2.15%
HK:0919
Modern Healthcare Technology Holdings Limited
0.08
<0.01
9.46%
HK:1830
Perfect Medical Health Management Limited
1.22
-0.06
-4.46%
HK:8483
Max Sight Group Holdings Limited
0.36
0.26
258.59%
HK:2521
Shenghui Cleanness Group Holdings Limited
0.81
0.39
92.86%
Miricor Enterprises Holdings Ltd Corporate Events
Miricor Refreshes Board, Strengthens Governance With New Independent Director
Sep 21, 2026
Miricor Enterprises Holdings Ltd announced a significant reshuffle of its independent non-executive directors and board committee leadership effective 21 September 2026. Long-serving independent non-executive director Mr. Cheng Yuk Wo has resigned...
Miricor Enterprises Updates Board and Committee Structure
Sep 21, 2026
Miricor Enterprises Holdings Ltd. has updated its board composition, confirming a mix of executive and independent non-executive directors led by Chairlady and Chief Executive Officer Ms. Lai Ka Yee Gigi. The announcement details the current membe...
Miricor Shareholders Unanimously Approve AGM Resolutions and Final Dividend
Sep 18, 2026
Miricor Enterprises Holdings Ltd reported that all resolutions tabled at its annual general meeting on 18 September 2026 were approved by shareholders, including the adoption of audited financial statements for the year ended 31 March 2026 and the...
Miricor Shareholders Unanimously Approve New Option Scheme at EGM
Sep 18, 2026
Miricor Enterprises Holdings Ltd reported that shareholders approved several key resolutions at an extraordinary general meeting held on 18 September 2026, including terminating its existing share option scheme and adopting a new one. The company ...
Miricor Seeks Shareholders’ Approval for New Share Option Scheme and Service Provider Sublimit
Aug 28, 2026
Miricor Enterprises Holdings Ltd has called an extraordinary general meeting for 18 September 2026 in Hong Kong to seek shareholder approval to terminate its existing share option scheme adopted in 2016 and replace it with a new share option schem...
Miricor sets September AGM to approve dividend, board changes and share issue mandate
Jul 23, 2026
Miricor Enterprises Holdings Ltd has called its annual general meeting for 18 September 2026 in Hong Kong, where shareholders will review the audited consolidated financial statements for the year ended 31 March 2026 and vote on a proposed final d...
Miricor Enterprises Declares Final Cash Dividend for FY2026
Jun 26, 2026
Miricor Enterprises Holdings Limited has declared a final ordinary cash dividend of HKD 0.10 per share for the financial year ended 31 March 2026, subject to shareholder approval on 18 September 2026. The dividend will be paid in Hong Kong dollars...
Miricor lifts profit and dividend despite revenue decline in FY2026
Jun 26, 2026
Miricor Enterprises Holdings reported revenue of HK$362.4 million for the year ended 31 March 2026, down 10.1% from the prior year, as the group faced softer demand and a more challenging operating environment in its beauty and wellness businesses...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.